Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Goldman Sachs
Pharma
J&J looks to offload remaining Kenvue stake in $3.75B deal
J&J is again cutting its holdings in Kenvue. This time, it's pursuing a "debt-for-equity" offering that looks to be worth about $3.75 billion.
Eric Sagonowsky
May 13, 2024 9:04am
China’s ZhenGe Biotech raises $100M in series C
Jan 11, 2022 9:54am
Settling with investors, Outcome founders bow out of exec roles
Jan 29, 2018 11:09am
Judge nixes investors' bid to freeze Outcome funds
Nov 14, 2017 9:43am
Eyeing drug sales, Amazon starts talks with PBMs: report
Sep 21, 2017 9:37am
Amazon could shake up pharma by teaming with a PBM: analysts
Aug 14, 2017 11:12am
